MATINAS BIOPHARMA HOLDINGS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Operating Leases, Future Minimum Payments, Due in Four Years of $616.00 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-04-01
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $616.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $610.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $610.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $610.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $616.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $610.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $610.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $610.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $657.00K 10-K · filed 2018-03-16 |
| 2017-09-30 | $732.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $731.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $735.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $751.00 10-K · filed 2017-03-31 |
| 2016-09-30 | $168.22K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $168.22K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $168.22K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $165.90K 10-K · filed 2016-03-30 |
| 2015-09-30 | $163.19K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $163.19K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $163.19K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $162.95K 10-K · filed 2015-03-31 |
| 2014-09-30 | $160.01K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $160.01K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $160.01K 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |